Catheter Precision, Inc. Files 8‑K on Financial Statements & Pro Forma Info

What Happened

• Catheter Precision, Inc. filed an 8‑K on July 29, 2026 (Accession No. 0001437749-26-024717) announcing that it has furnished financial statements and the pro forma financial information required under Item 9.01. [Include any specifics here: e.g., "The filing includes audited financials for the year ended Dec 31, 2025" or "pro forma information reflecting the July 15, 2026 acquisition of X Corp."]

Key Details

• Exhibit [XX]: [Title] — [e.g., audited financial statements for year ended MM/DD/YYYY].
• Pro forma adjustment(s): [briefly state amounts or effects, e.g., "Pro forma net loss of $X and pro forma assets of $Y after the transaction."]
• Effective date(s): [e.g., "Transaction closing date July 15, 2026" or "financial statements filed as of July 29, 2026"].
• Other exhibits: [list any material exhibits like legal opinions, consents, or statements by accountants if included].

Why It Matters

• The filing supplies the formal financial statements and pro forma numbers investors need to assess recent corporate actions (such as an acquisition, disposition, or recapitalization). These figures can change reported revenue, assets, liabilities, or net loss and affect valuation and investor decisions.
• Investors should review the attached pro forma adjustments and accountant consents (if any) to understand how the transaction(s) materially alter historical financials and future comparisons.

— Send the Item 9.01 text or exhibits and I’ll generate the finalized TITLE, SHORT_DESCRIPTION and SUMMARY with precise numbers, names and dates.